Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma

Hematology and Cell Therapy

Volumn 38, Issue 4, 1996, Pages 297-304

  Gisselbrecht, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

aggressive histology; allogeneic; autologous; non Hodgkin's lymphoma; transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

AUTOTRANSPLANTATION; CLINICAL TRIAL; HUMAN; NONHODGKIN LYMPHOMA; REVIEW; STEM CELL TRANSPLANTATION;

EID: 0029785910     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0297-0     Document Type: Review

References (43)

1. Armitage JO, Weisenburger DD, Hutchins M, et al (1986) Chemotherapy for diffuse large-cell lymphoma-Rapidly responding patients have more durable remission. J Clin Oncol 4 : 160-164
2. Baro J, Richard C, Calavia J, et al (1991) Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features. Bone marrow Transplantation 8 : 283-289
3. Bosly A, Coiffier B, Gisselbrecht C, et al (1992) For the Groupe d'Etude des Lymphomes Agressifs. Bone marrow transplantation significantly prolongs survival after relapse in aggressive lymphoma patients treated with the LNH84 regimen. J. Clin Oncol 10 : 1615-1623
4. Brice P, Marolleau JP, Pautier P, et al (1996) Hematologic recovery and survival of lymphoma patients after autologous stem cell transplantation (ASCT): Comparision of bone marrow with peripheral blood progenitor cell (PBSC). Leuk Lymphoma (in press)
5. Cabanillas F, Hagemeister FB, Bodey GP, et al (1982) IMVP 16: An effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 60 : 693-697
6. Cabanillas F, Hagemeister FB, McLaughlin P, et al (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 3: 407-412
7. Chopra R, Goldstone AH, Pearce R, et al (1992) Autologous versus allogenic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 10 : 1690-1695
8. Coiffier B, Gisselbrecht C, Herbrecht R, et al (1989) LNH84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7 : 1018-1026
9. Coleman CN, Picozzi VJ, Cox RS, et al (1986) Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 4 : 399-404
10. Fisher RI, Gaynor E, Dahlberg S, et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regiments for advanced non-Hodgkin's lymphoma. N Engl J Med 328 : 1002-1006
11. Gianni, AM (1994) 5-Year update of the Milan Cancer Institute randomized trial of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large-cell lymphomas. Proc Am Soc Clin Oncol 13: 373
12. Gisselbrecht C, Lepage E, Fermand JP, et al (1984) Intensive induction treatment in non-Hodgkin lymphomas with various grades of malignancy. Cancer Research Workshop, Sotto, Vroussos, Vincent Ed, Karger, Grenoble, p 195-199
13. Gisselbrecht C, Lepage E, Morel P, et al For the GELA (1996) Short and intensified treatment with autologous stem cell transplantation (ASCT) versus ACVB regimen in poor prognosis aggressive lymphoma (abstract). Br J Haematol 93 : 561
14. Gordon LI, Harrington DP, Andersen J, et al (1992) Comparison of a second generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Eng J Med 327 : 1342-1349
15. Gribben JG, Goldstone AH, Linch DC, et al (1989) Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who are still responsive to conventional-dose therapy. J Clin Oncol 7 : 1621-1629
16. Gribben JG, Freedman AS, Neuberg D, et al (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325: 1525-1533
17. Gulati SC, Shank B, Black P, et al (1988) Autologous bone marrow transplantation for patients with poor prognosis lymphoma. J Clin Oncol 6 : 1303-1313
18. Haioun C, Lepage E, Gisselbrecht C, et al (1994) for the GELA. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high grade non-Hodgkin's lymphoma in first complete remission. A study of 464 patients. J Clin Oncol 12: 2543-2551
19. Haioun C (1995) Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non-Hodgkin's lymphoma (NHL) in first complete remission (CR): A study of 542 patients (LNH87-2 protocol). American Society of Hematology, (Washington 1995) (abstract). Blood 86 : 1816
20. C Haioun, Lepage E, Gisselbrecht C, et al (1995) Autologous transplantation versus conventional salvage therapy in aggressive non-Hodgkin's lymphoma (NHL) partially responding to first line chemotherapy. Study of 96 patients enrolled in the LNH87-2 protocol (abstract). Blood 86 : 833
21. Jones RJ, Ambinder RF, Piantadosi S, et al (1991) Evidence of a graft versus lymphoma effect associated with allogenic bone marrow transpalntation. Blood 77 : 649-653
22. Lundberg JH, Hansen RM, Chitambar CR, et al (1991) Allogenic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA identical and alternative donors. J Clin Oncol 9 : 1848-1859
23. Martelli M, Vignetti M, Zinzani PL, et al (1996) High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized Italian multicenter study. J Clin Oncol 14 : 534-542
24. Morel P, Lepage E, Brice P, et al (1992) Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 10 : 1078-1085
25. Milpied N, Ifrah N, Kuentz M, et al (1989) Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 73 : 82-87
26. Murphy SB, Fairclough DL, Hutchinson RE, et al (1989) Non-Hodgkin's lymphoma of childhood: An analysis of the histology, staging and response to treatment of 338 cases at a single institution. J Clin Oncol 7: 186-193
27. Nademanee A, Schmidt G, O'Donnell MR et al (1992) High dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: A pilot study. Blood 80 : 1130-1134
28. Patte C, Philip T, Rodary C, et al (1986) Improved survival rate in children with stage III and IV B-cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 4 : 1219-1226
29. Pettengel R, Radford JA, Morgenstern GR, et al (1996) Survival benefit from progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma. J Clin Oncol 14 : 586-592
30. Philip T, Armitage JO, Spitzer G, et al (1987) High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high grade non-Hodgkin lymphoma. N Engl J Med 316 : 1493-1498
31. Philip T, Hartman O, Biron P, et al (1988) High dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. J Clin Oncol 6 : 1118-1124
32. Philip T, Guglielmi C, Hagenbeek A, et al (1995) A prospective randomized study comparing autologous bone marrow transplantation (ABMT) and salvage chemotherapy (DHAP) in sensitive relapse of non-Hodgkin's lymphoma (NHL): final analysis of the PARMA study. N Engl J Med 333 : 1540-1545
33. Robertson LE, Redman JR, Bulter JJ, et al (1991) Discordant bone marrow involvement in diffuse large-cell lymphoma: A distinct clinical-pathologic entity associated with a continuous risk of relapse. J Clin Oncol 9 : 236-242
34. Salles G, Shipp MA, Coiffier B (1994) Chemotherapy of non-Hodgkin's aggressive lymphomas. Sem Hematology 31: 46-69
35. Santini G, Congui AM, Coser P, et al (1991) Autologous bone marrow transplantation for adult advanced stage adult lymphoblastic lymphoma in first CR: A study of the NHLGSG. Leukemia 5[Suppl 1] : 42-45
36. Shipp MA, Harrington DP, Anderson JR, et al (1993) Development of a predictive model for aggressive lymphoma: The International Non-Hodgkins Lymphoma Prognostic Factors Project. N Engl J Med 329 : 987-994
37. Sharp JG, Kessinger A, Mann S, et al (1996) Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J Clin Oncol 14: 214-219
38. Sweetenham JW, Liberti G, Pearce R, et al (1994) High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. J Clin Oncol 12 : 1358-1365
39. Sweetenham JW, Pearce R, Taghipour G, et al for the EBMT lymphoma Working Party (1995) Adult Burkitt's and Burkitt-line non-Hodgkin's lymphoma (NHL) favourable outcome for patients undergoing high dose therapy and autologous stem cell transplantation (ASCT) in first remission or chemosensitive relapse : results from the EBMT (abstract). Blood 86 : 832
40. Velasquez WS, Cabanillas F, Salvadore P, et al (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara C and dexamethasone (DHAP). Blood 71 : 117
41. Verdonck LF Dekker AW, Gijsbert C, et al (1992) Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission. J Clin Oncol 10 : 644-646
42. Verdonck LF, Van Putten WLJ, Hagenbeek A, et al (1995) Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 332 : 1045-1092
43. Vose MJ, Anderson JR, Kessinger A, et al (1993) High dose chemotherapy and autologous hematopoietic stem cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11 : 1846-1851